S100A9 and glioblastoma: This finding is supported by a recent study where it has been demonstrated that the cell origin of S100A8 and S100A9 in GBM tissue as polymorphonuclear-myeloid derived suppressor cells (PMN-MDSCs)32, which are known to contribute to the suppressive immune environment36.